169 related articles for article (PubMed ID: 23098448)
21. Spectrum of epithelial cell abnormalities of uterine cervix in a cervical cancer screening programme: implications for resource limited settings.
Gupta S; Sodhani P; Halder K; Chachra KL; Sardana S; Singh V; Sehgal A
Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):238-42. PubMed ID: 16920248
[TBL] [Abstract][Full Text] [Related]
22. Screening capacity and cost-effectiveness of the human papillomavirus test versus cervicography as an adjunctive test to Pap cytology to detect high-grade cervical dysplasia.
Song T; Seong SJ; Lee SK; Kim BR; Ju W; Kim KH; Nam K; Sim JC; Kim TJ
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():112-116. PubMed ID: 30682600
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of costs and benefits of advances in cytologic technology. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
Melamed MR; Hutchinson ML; Kaufman EA; Schechter CB; Garner D; Kobler TP; Krieger PA; Reith A; Schenck U
Acta Cytol; 1998; 42(1):69-75. PubMed ID: 9479325
[TBL] [Abstract][Full Text] [Related]
24. Direct comparison of liquid-based and conventional cytology in a South African screening trial.
Taylor S; Kuhn L; Dupree W; Denny L; De Souza M; Wright TC
Int J Cancer; 2006 Feb; 118(4):957-62. PubMed ID: 16152600
[TBL] [Abstract][Full Text] [Related]
25. Costs and outcomes of PAPNET secondary screening technology for cervical cytologic evaluation. A community hospital's experience.
Brotzman GL; Kretzchmar S; Ferguson D; Gottlieb M; Stowe C
Arch Fam Med; 1999; 8(1):52-5. PubMed ID: 9932072
[TBL] [Abstract][Full Text] [Related]
26. Study of a manual method of liquid-based cervical cytology.
Kavatkar AN; Nagwanshi CA; Dabak SM
Indian J Pathol Microbiol; 2008; 51(2):190-4. PubMed ID: 18603678
[TBL] [Abstract][Full Text] [Related]
27. Detection Rate of High-Grade Cervical Neoplasia and Cost-Effectiveness of High-Risk Human Papillomavirus Genotyping with Reflex Liquid-based Cytology in Cervical Cancer Screening.
Tay SK; Lin LE; Goh RC
Ann Acad Med Singap; 2017 Jul; 46(7):267-273. PubMed ID: 28821890
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness analysis of cervical cancer screening strategies based on the Papanicolaou smear test in Korea.
Ko MJ; Kim J; Kim Y; Lee YJ; Hong SR; Lee JK
Asian Pac J Cancer Prev; 2015; 16(6):2317-22. PubMed ID: 25824757
[TBL] [Abstract][Full Text] [Related]
29. Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis.
Karnon J; Peters J; Platt J; Chilcott J; McGoogan E; Brewer N
Health Technol Assess; 2004 May; 8(20):iii, 1-78. PubMed ID: 15147611
[TBL] [Abstract][Full Text] [Related]
30. Critical Analyses of the Introduction of Liquid-Based Cytology in a Public Health Service of the State of São Paulo, Brazil.
Longatto-Filho A; Levi JE; Martins TR; Cohen D; Cury L; Villa LL; Eluf-Neto J
Acta Cytol; 2015; 59(3):273-7. PubMed ID: 26279162
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of visual inspection with acetic acid and Lugol's iodine as cervical cancer screening tools in a low-resource setting.
Qureshi S; Das V; Zahra F
Trop Doct; 2010 Jan; 40(1):9-12. PubMed ID: 20008057
[TBL] [Abstract][Full Text] [Related]
32. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India.
Arbyn M; Sankaranarayanan R; Muwonge R; Keita N; Dolo A; Mbalawa CG; Nouhou H; Sakande B; Wesley R; Somanathan T; Sharma A; Shastri S; Basu P
Int J Cancer; 2008 Jul; 123(1):153-60. PubMed ID: 18404671
[TBL] [Abstract][Full Text] [Related]
33. Economic analysis of human papillomavirus triage, repeat cytology, and immediate colposcopy in management of women with minor cytological abnormalities in Sweden.
Ostensson E; Fröberg M; Hjerpe A; Zethraeus N; Andersson S
Acta Obstet Gynecol Scand; 2010 Oct; 89(10):1316-25. PubMed ID: 20846064
[TBL] [Abstract][Full Text] [Related]
34. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.
Flores Y; Shah K; Lazcano E; Hernández M; Bishai D; Ferris DG; Lörincz A; Hernández P; Salmerón J;
Salud Publica Mex; 2002; 44(4):335-44. PubMed ID: 12216521
[TBL] [Abstract][Full Text] [Related]
35. Cytology versus HPV testing for cervical cancer screening in the general population.
Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
[TBL] [Abstract][Full Text] [Related]
36. Benefits and costs of using HPV testing to screen for cervical cancer.
Mandelblatt JS; Lawrence WF; Womack SM; Jacobson D; Yi B; Hwang YT; Gold K; Barter J; Shah K
JAMA; 2002 May; 287(18):2372-81. PubMed ID: 11988058
[TBL] [Abstract][Full Text] [Related]
37. Comparison of visual inspection with acetic acid and cervical cytology to detect high-grade cervical neoplasia among HIV-infected women in India.
Sahasrabuddhe VV; Bhosale RA; Kavatkar AN; Nagwanshi CA; Joshi SN; Jenkins CA; Shepherd BE; Kelkar RS; Sahay S; Risbud AR; Vermund SH; Mehendale SM
Int J Cancer; 2012 Jan; 130(1):234-40. PubMed ID: 21387289
[TBL] [Abstract][Full Text] [Related]
38. Follow-up with histopathology and HPV testing on LSIL cytology in China's largest academic woman's hospital.
Tao X; Zhang H; Zhang H; Xiao J; Li J; Zhou X; Wang L; Zhao C
Cancer Cytopathol; 2019 Apr; 127(4):258-266. PubMed ID: 30892831
[TBL] [Abstract][Full Text] [Related]
39. The impact of new technologies in cervical cancer screening: results of the recruitment phase of a large randomised controlled trial from a public health perspective.
Giorgi-Rossi P; Segnan N; Zappa M; Naldoni C; Zorzi M; Confortini M; Merito M; Cuzick J; Ronco G;
Int J Cancer; 2007 Dec; 121(12):2729-34. PubMed ID: 17724715
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of liquid-based cytology with or without hybrid-capture II HPV test compared with conventional Pap smears: a study by the French Society of Clinical Cytology.
Cochand-Priollet B; Cartier I; de Cremoux P; Le Galès C; Ziol M; Molinié V; Petitjean A; Dosda A; Merea E; Biaggi A; Gouget I; Arkwright S; Vacher-Lavenu MC; Vielh P; Coste J
Diagn Cytopathol; 2005 Nov; 33(5):338-43. PubMed ID: 16240398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
